5F-PB-22: Difference between revisions
>Oskykins |
>Oskykins |
||
Line 78: | Line 78: | ||
==Legal issues== | ==Legal issues== | ||
5F-PB-22 was developed to bypass drug prohibition laws which have banned the possession and sale of many synthetic cannabinoids. As such, it remains legal in most of the world. | |||
*'''United Kingdom''' - This drug is illegal under the Psychoactive Substance Act, which came into effect on May 26th, 2016. | *'''United Kingdom''' - This drug is illegal under the Psychoactive Substance Act, which came into effect on May 26th, 2016. | ||
*'''United States | *'''United States''' - In January 2014, 5F-PB-22 was designated as a Schedule I controlled substance in the United States.<ref>http://www.deadiversion.usdoj.gov/fed_regs/rules/2014/fr0110_10.htm</ref> | ||
*'''Germany''' | *'''Germany''' - On December 13, 2014 5F-PB-22 was added to the controlled substance act ("BtMG"), making it illegal to produce, sell or possess.<ref>Achtundzwanzigste Verordnung zur Änderung betäubungsmittelrechtlicher Vorschriften (28. BtMÄndV)| http://www.buzer.de/gesetz/11392/a189949.htm</ref> | ||
*'''Latvia | *'''Latvia''' - 5F-PB-22 is a Schedule I drug.<ref>Noteikumi par Latvijā kontrolējamajām narkotiskajām vielām, psihotropajām vielām un prekursoriem (Indola-3-karbonskābes esteri) | http://likumi.lv/doc.php?id=121086</ref> | ||
==See also== | ==See also== |